Company news
Sonoma Pharmaceuticals, Inc. news in 2022
Sonoma Pharmaceuticals, Inc.'s news releases, calls and decks from 2022, newest first.
Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results
November 13, 2022
Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States
October 26, 2022
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany
October 5, 2022
Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results
August 10, 2022
Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supply
August 1, 2022
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results
July 12, 2022
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19
May 31, 2022
Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.
May 2, 2022
Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa
March 29, 2022
Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results
February 10, 2022
Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China
January 19, 2022
Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022
January 4, 2022
Decks in 2022
- Investor Presentation (January 2022)
Investor deck · 29 slides · Jan 6, 2022